Abstract:Asian American (24 million people) and Native Hawaiian and other Pacific Islander (1.7 million people) individuals represent 8% of the US population. 1 Cancer is the leading cause of death among many Asian American groups (Chinese, Filipino, Vietnamese, and Korean) and is the second leading cause of death among Native Hawaiian, Indian, and Japanese American people. 1 A growing body of research has focused on cancer among these very diverse groups, elucidating their unique and dynamic cancer risk factors, epidemiology, and access to care. 2 ,3 Zhu et al 4 evaluated cancer-specific mortality (CSM) rates for Asian American, Native Hawaiian, and other Pacific Islander individuals from 1999 to 2020 using the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research database. They found that for these groups in aggregate, CSM rates decreased over the past 2 decades and that decreases were greater among men than among women. The CSM rates among women increased for cancers of the uterus and the brain and central nervous system but decreased for other cancer sites. Upon analysis by age, women aged 65 to 74 years experienced the greatest increase in mortality from uterine cancer. Among men, CSM rates decreased overall, with the greatest decreases in cancers of the stomach and lung. Decreases in CSM were greatest in cancers of the liver and lung among men aged 35 to 44 years; however, colorectal cancer mortality increased among men aged 45 to 54 years, and after a decrease from 2002 to 2012, prostate cancer increased among men aged 64 to 74 years (from 2012 to 2020). The authors found increased mortality for pancreatic cancer in the Midwest and for uterine cancer and liver cancer across all US census regions. The study by Zhu et al 4 highlights the need to further study and address the cancer burden among these rapidly growing populations. 1 Their work is nationally representative and may inform cancer policy. Their findings illustrate how cancer mortality has changed over time, reflecting changes in risk factors, screening rates, and timely and equitable access to quality cancer care. 2 -4 The study is limited by the aggregation of diverse Asian American and Pacific Islander groups, who exhibit some of the widest disparities in social determinants of health across census groups, 1 -3 a limitation inherent in the dataset that masks heterogeneity in cancer mortality. 1 -3 Heterogeneity in cancer mortality is notable. The age-adjusted mortality rate for all cancer subsites is 142 per 100 000 for Native Hawaiian and Pacific Islander patients, 91 per 100 000 for Asian American patients, and 153 per 100 000 for White patients. 1 For uterine cancer, the age-adjusted mortality rate is 16 per 100 000 for Native Hawaiian and Pacific Islander patients compared with 5 per 100 000 for White patients and 3 per 100 000 for Asian American patients. 1 For breast cancer, 5-year relative survival is 94% for Japanese American and 93% for White and Chinese patients compared with 72% for Tongan, 73% for Chamorro and Guamanian, and 74% for Samoan patients. 1 For cancers of the lung and bronchus, 5-year relative survival is 37% for Thai, 36% for Chinese, 35% for Pakistani, and 29% for Indian patients compared with 25% for White, 18% for Samoan, 15% for Tongan, and 11% for Laotian patients. 1 Such heterogeneity in mortality may reflect differences across the continuum of disease leading up to mortality estimates. 2 Considering the current study and in the context of such heterogeneity, what are the next steps? First, further disaggregated research is needed to examine the drivers of these temporal changes. Although CSM has decreased overall for Asian American, Native Hawaiian, and Pacific Islander patients, decreases in lung CSM may be driven by relatively better survival among Chinese and Indian patients (and perhaps to a lesser extent by the smaller Thai and Pakistani populations) but may not reflect the substantially lower survival among several Pacific Islander and Southeast Asian (eg, Laotian) groups. 1 Increases in uterine CSM may reflect the burden of disease among Native Hawaiian and Pacific Islander individuals, among whom focused studies and interventions are needed. 1 ,3 Further research could explore how cancer risk compares between immigrants and people in their countries of origin and how cancer risk changes across generations of immigrants. 5 Parallels between immigrants and their countries of origin may inform targeted diagnostics, as exemplified by the high rate of gastric cancer among Korean American individuals reflecting epidemiology in Korea. 1 ,5 Such work may also elucidate how risk changes in th -Abstract Truncated-

Abstract A072: Lung cancer survival disparities: A disaggregated AANHPI study of the SEER database

Identifying Asian American lung cancer disparities: A novel analytic approach

Racial and Ethnic Disparities in Lung Adenocarcinoma Survival: A Competing-Risk Model.

Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders

Abstract A074: Racial-Ethnic Disparities in Cancer Survival and Stages: A Focus on South Asian Americans

Abstract 4821: Lung cancer survival disparities by ethnicity in Guam, 2001-2020

Disparities in Cancer Mortality among Disaggregated Asian American Subpopulations, 2018–2021

Disparities in survival in Asian American, Native Hawaiian, and Pacific Islander patients with gastric adenocarcinoma: An NCDB analysis.

Disaggregated Cancer Research and Intervention for Asian American and Pacific Islander People

Cancer Mortality Disparities among Asian American and Native Hawaiian/Pacific Islander Populations in California

Abstract B178: Examining ovarian cancer survival by Asian American ethnic subgroup: An analysis of California Cancer Registry data

Abstract A086: Racial and ethnic disparities in prostate cancer survival in the Multiethnic Cohort Study (MEC)

Characterizing disparities in receipt of palliative care for Asian Americans, Native Hawaiians, and Pacific Islanders with metastatic cancer in the United States

Comparative Analysis of Clinicopathologic Features Of, Treatment In, and Survival of Americans with Lung or Bronchial Cancer.

Abstract 2134: Disaggregating breast cancer mortality trends in Asian American women from 2005-2020

Abstract 4831: Racialized economic segregation and disparities in late-stage diagnosis, treatment and mortality among patients with non-small cell lung cancer

Abstract A046: Disparities in cancer burden and survival rates in persistent poverty communities in Los Angeles County

Abstract C040: Racial and ethnic differences in breast cancer prognosis and survival in a multiethnic cohort of Asian American breast cancer patients compared with non-Latina White patients at Kaiser Permanente Northern California

Survival Difference of Colorectal Adenocarcinoma Among Racial and Ethnic Minority Groups: A SEER Database Study

Abstract A069: Leading causes of death among Asian American individuals compared with Pacific Islander individuals in the United States, 2018-2020

A bird's-eye view of disparity from public historic cancer mortality data in the US: Advocacy for gastrointestinal cancers and for inter-agency data harmonization.